Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

Clinical Endocrinology

Volumn 47, Issue 5, 1997, Pages 571-581

  Johannsson, Gudmundur ^a   Rosén, Thord ^a   Bengtsson, Bengt Åke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CORTISONE ACETATE; DESMOPRESSIN; ESTRADIOL; GLUCOSE; GROWTH HORMONE; INSULIN; LEVOTHYROXINE; LIPOPROTEIN A; OSTEOCALCIN; PARATHYROID HORMONE; POTASSIUM; RECOMBINANT GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY SURFACE; BODY WEIGHT; BONE MINERAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; EDEMA; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; HORMONE RESPONSE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPITUITARISM; INDIVIDUALIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; TOTAL BODY POTASSIUM;

EID: 0030724963     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.3271123.x     Document Type: Article

References (42)

1. Amato, G., Carella, C., Fazio, S., La Montagna, G., Cittadini, A., Sabalini, D., Marciano-Mone, C., Saccá, J. & Bellastella, A. (1993) Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. Journal of Clinical Endocrinology and Metabolism, 77, 1671-1676.
2. Amato, G., Izzo, G., La Montagna, G. & Bellastella, A. (1996) Low dose recombinant human growth hormone normalizes bone metabolism and cortical bone density and improves trabecular bone density in growth hormone deficient adults without causing adverse effects. Clinical Endocrinology, 45, 27-32.
3. Bengtsson, B.-Å., Eden, S., Lönn, L., Kvist, H., Stokland, A., Lindstedt, G., Bosaeus, I., Tölli, J., Sjöström, L. & Isaksson, O.G.P. (1993) Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. Journal of Clinical Endocrinology and Metabolism, 76, 309-317.
4. Bruce, A., Andersson, M., Arvidsson, B. & Isaksson, B. (1980) Body composition. Prediction of normal body potassium, body water and body fat in adults on the basis of body height, body weight and age. Scandinavian Journal of Clinical and Laboratory Investigation, 40, 461-473.
5. Caidahl, K., Edén, S. & Bengtsson, B.-Å. (1994) Cardiovascular and renal effects of growth hormone. Clinical Endocrinology, 40, 393-400.
6. Cuneo, R.C., Salomon, F., McGauley, G.A. & Sönksen, P.H. (1992) The growth hormone deficiency syndrome in adults. Clinical Endocrinology, 37, 387-397.
7. De Boer, H., Block, G.-J. & Van der Veen, E.A. (1995a) Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
8. De Boer, H., Block, G.J., Popp-Snijders, C., Stuurman, L., Baxter, R.C. & Van der Veen, E. (1996) Monitoring of growth hormone replacement therapy in adults, based on measurements of serum markers. Journal of Clinical Endocrinology and Metabolism, 81, 1371-1377.
9. De Boer, H., Blok, G.J., Voerman, B., De Vries, P., Popp-Snijders, C. & Van der Veen, E. (1995b) The optimal growth hormone replacement dose in adults, derived from bioimpedance analysis. Journal of Clinical Endocrinology and Metabolism, 80, 2069-2076.
10. De Boer, H., Blok, G.J., Voerman, H.J., de Vries, P.M.J. & van der Veen, E.A. (1992) Body composition in adult growth hormone-deficient men, assessed by anthropodometry and bioimpedance analysis. Journal of Clinical Endocrinology and Metabolism, 75, 833-837.
11. Ellis, K., Yasumura, S., Vartsky, D., Vaswani, A. & Conn, S.H. (1982) Total body nitrogen in health and disease: effects of age, weight, height and sex. Journal of Laboratory and Clinical Medicine, 99, 917-926.
12. Chiron, L.J., Thompson, J.L., Holloway, L., Hintz, R.L., Butterfield, G.E., Hoffman, A.R. & Marcus, R. (1995) Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. Journal of Bone and Mineral Research, 10, 1844-1852.
13. Ho, K.K.Y., Evans, W.S., Blizzard, R.M., Veldhuis, J.D., Merriam, G.R., Samojlik, E., Furlanetto, R., Rogol, A.D., Kaiser, D.L. & Thorner, M.O. (1987) Effects of sex and age on the 24-hour profile of growth hormone secretion in man. Importance of endogenous estradiol concentrations. Journal of Clinical Endocrinology and Metabolism, 64, 51-58.
14. Hock, J.M., Centrella, M. & Canalis, E. (1988) Insulin-like growth factor I has independent effects on bone matrix formation and cell replication. Endocrinology, 122, 254-260.
15. Hoffman, D.M., O'Sullivan, A.J., Baxter, R.C. & Ho, K.K.Y. (1994) Diagnosis of growth hormone deficiency in adults. Lancet, 343, 1064-1068.
16. Holmes, S.J. & Shalet. S.M. (1995) Which adults develop side-effects of growth hormone replacement? Clinical Endocrinology, 43, 143-149.
17. Hyes, F.J., Fiad, T.M. & McKenna, T.J. (1996) Can baseline characteristics of growth hormone (GH)-deficient adults predict a favourable response to GH therapy? 10th International Congress of Endocrinology, San Francisco, p. 2-278.
18. Iranmanesh, A., Lizarralde, G. & Veldhuis, J.D. (1991) Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. Journal of Clinical Endocrinology and Metabolism, 73, 1081-1088.
19. Isgaard, J., Carlsson, L., Isaksson, O.G.P. & Jansson, J.-O. (1988) Pulsatile intravenous growth hormone (GH) infusion to hypophysectomized rats increases insulin-like growth factor I messenger ribonucleic acid in skeletal tissues more effectively than continuous GH infusion. Endocrinology, 123, 2605-2610.
20. Johannsson, G., Bengtsson, B.-A., Andersson, B., Isgaard, J. & Caidahl, K. (1996a) Long-term cardiovascular effects of growth hormone treatment in GH-deficient adults: preliminary data from a small group of patients. Clinical Endocrinology, 45, 305-314.
21. Johannsson, G., Bjarnason, R., Bramnert, M., Carlsson, L.M.S., Degerblad, M., Manhem, P., Rosén, T., Thorén, M. & Bengtsson, B.-A. (1996b) The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH binding protein, body mass index, age and gender. Journal of Clinical Endocrinology and Metabolism, 81, 1575-1581.
22. Johannsson, G., Oscarsson, J., Rosén, T., Wiklund, O., Olsson, G., Wilhelmsen, L. & Bengtsson, B.-Å. (1995) Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults: influence of gender and apo(a) and apoE phenotypes. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 2142-2150.
23. Johannsson, G., Rosén, T., Bosaeus, I., Sjöström, L. & Bengtsson, B.-Å. (1996c) Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism. 81, 2865-2873.
24. Johannsson, G., Rosén, T., Lindstedt, G., Bosaeus, I. & Bengtsson, B.-Å. (1996d) Effects of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency. Endocrinology and Metabolism, 3 (Suppl. A), 3-12.
25. Johansson, A.G., Lindh, E., Blum, W.F., Kollerup, G., Sørensen, O.H. & Ljunghall, S. (1996) Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis. Journal of Clinical Endocrinology and Metabolism, 81, 44-48.
26. Jørgensen, J.O.L., Moller, N., Lauritzen, T. & Christiansen, J.S. (1990) Pulsatile versus continuous intravenous administration of growth hormone (GH) in GH-deficient patients: effects of circulating insulin-like growth factor-I and metabolic indices. Journal of Clinical Endocrinology and Metabolism, 70, 1616-1623.
27. Jørgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jørgensen, J., Ingemann-Hansen, T., Skakkebsek, N.E. & Christiansen, J.S. (1989) Beneficial effect of growth hormone treatment in GH-deficient adults. Lancet, i, 1221-1225.
28. Landin-Wilhelmsen, K., Wilhelmsen, L., Lappas, G., Rosén, T., Lindstedt, G., Lundberg, P.A. & Bengtsson, B.-Å. (1994) Serum insulin-like growth factor I in a random population sample of men and women: relationship to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Journal of Clinial Endocrinology and Metabolism, 41, 351-357.
29. Matthews, J.N.S., Altman, D.G., Campbell, M.J. & Royston, P. (1990) Analysis of serial measurements in medical research. British Medical Journal, 300, 230-235.
30. Mazess, R.B., Barden, H.S., Bisek, J.P. & Hanson, J. (1990) Dual-energy X-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. American Journal of Clinical Nutrition, 51, 1106-1112.
31. Møller, J., Jørgensen, J.O.L., Lauersen, T., Frystyk, J., Næraa, R.W. Ørskov, H. & Christiansen, J.S. (1993) Growth hormone dose regimens in adult GH deficiency, effects on biochemical growth markers and metabolic parameters. Clinical Endocrinology, 39, 403-408.
32. Nilsson, A., Swolin, D., Enerback, S. & Ohlsson, C. (1995) Expression of functional growth hormone receptors in cultured human osteoblast-cells. Journal of Clinical Endocrinology and Metabolism, 80, 3483-3488.
33. Orme, S.M., Sebastian, J.P., Oldroyd, B., Stewart, S.P., Grant, P.J., Stickland, M.H., Smith, M.A. & Belchetz, P.E. (1992) Comparison of measures of body composition in a trial of low dose growth hormone replacement therapy. Clinical Endocrinology, 37, 453-459.
34. Oscarsson, J., Johannsson, G., Johansson, J.-O., Lundberg, P.-A., Lindstedt, G. & Bengtsson, B.-A. (1997) Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults. Clinical Endocrinology, 46, 63-68.
35. Oscarsson, J., Ottosson, M., Johansson, J.-O., Wiklund, O., Marin, P., Björntorp, P. & Bengtsson, B.-Å. (1996) Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GH-deficient adults: II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabolism, 45, 370-377.
36. Rosén, T. & Bengtsson, B.-Å. (1990) Premature mortality due to cardiovascular diseases in hypopituitarism. Lancet, 336, 285-288.
37. Rosengren, A., Wilhelmsen, L., Eriksson, E., Risberg, B. & Wedel, H. (1990) Lipoprotein(a) and coronary heart disease. A prospective case-control study in a general population sample of middle aged men. British Medical Journal, 301, 1248-1251.
38. Rudman, D., Kutner, M.H., Rogers, C.M., Lubin, M.F., Flemming, G.A. & Bain, R.P. (1981) Impaired growth hormone secretion in the adult population. Relation to age and adiposity. Journal of Clinical Investigation, 67, 1361-1369.
39. Salomon, F., Cuneo, R.C., Hesp, R. & Sönksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
40. Slootweg, M.C., Most, W.W., van Beek, E., Schot, L.P.C., Papapoulos, S.E. & Löwik, C.W.G.M. (1992) Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-I. Journal of Endocrinology, 132, 433-438.
41. Weaver, J.U., Monsson, J.P., Noonan, K., John, W.O., Edwards, A., Evans, K.A. & Cunningham, J. (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 80, 153-159.
42. Wiklund, O., Fager, G., Craig, I.H., Wilhelmsson, C.E., Vedin, A., Olofsson, S.-O., Bondjers, G. & Wilhelmsen, L. (1980) Alphalipo-protein cholesterol in relation to acute myocardial infarction and its risk factors. Scandinavian Journal of Clinical and Laboratory Investigation, 40, 239-247.